BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36085118)

  • 21. Advanced extremity soft tissue sarcoma: prognostic effect of isolated limb perfusion in a series of 88 patients treated at a single institution.
    Pennacchioli E; Deraco M; Mariani L; Fiore M; Mussi C; Collini P; Olmi P; Casali PG; Santinami M; Gronchi A
    Ann Surg Oncol; 2007 Feb; 14(2):553-9. PubMed ID: 17122991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiotherapy for soft tissue sarcomas after isolated limb perfusion and surgical resection: essential for local control in all patients?
    Deroose JP; Burger JW; van Geel AN; den Bakker MA; de Jong JS; Eggermont AM; Verhoef C
    Ann Surg Oncol; 2011 Feb; 18(2):321-7. PubMed ID: 21049306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Feasibility and efficacy of external beam radiotherapy after hyperthermic isolated limb perfusion with TNF-alpha and melphalan for limb-saving treatment in locally advanced extremity soft-tissue sarcoma.
    Olieman AF; Pras E; van Ginkel RJ; Molenaar WM; Schraffordt Koops H; Hoekstra HJ
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):807-14. PubMed ID: 9531364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neoadjuvant isolated limb perfusion in newly diagnosed untreated patients with locally advanced soft tissue sarcomas of the extremities: the Gustave Roussy experience.
    Assi T; Cavalcanti A; Le Cesne A; Faron M; Honart JF; Hadiji A; Camuzard O; Ibrahim T; LePéchoux C; Mir O; Dumont S; Terrier P; Adam J; Honoré C
    Clin Transl Oncol; 2019 Sep; 21(9):1135-1141. PubMed ID: 30656606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Results of isolated hyperthermic extremity perfusion in soft tissue sarcomas within the scope of a multimodality treatment concept].
    Schwarzbach M; Lehnert T; Willeke F; Hinz U; Herfarth C
    Chirurg; 1996 Dec; 67(12):1237-43. PubMed ID: 9081786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcome and prognostic factor analysis of 217 consecutive isolated limb perfusions with tumor necrosis factor-alpha and melphalan for limb-threatening soft tissue sarcoma.
    Grunhagen DJ; de Wilt JH; Graveland WJ; Verhoef C; van Geel AN; Eggermont AM
    Cancer; 2006 Apr; 106(8):1776-84. PubMed ID: 16541435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fractures after multimodality treatment of soft tissue sarcomas with isolated limb perfusion and radiation; likely to occur and hard to heal.
    Seinen JM; Jutte PC; Been LB; Pras E; Hoekstra HJ
    Eur J Surg Oncol; 2018 Sep; 44(9):1398-1405. PubMed ID: 29789188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Locally advanced soft-tissue sarcomas. An innovating triad to avoid amputation: isolated limb perfusion, TNFalpha, and free microsurgical flap].
    Germain MA; Bonvalot S; Rimareix F; Missana CM
    Bull Acad Natl Med; 2010 Jan; 194(1):51-65; discussion 65-7. PubMed ID: 20669559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High dose tumor necrosis factor-alpha and melphalan administered via isolated limb perfusion for advanced limb soft tissue sarcoma results in a >90% response rate and limb preservation.
    Gutman M; Inbar M; Lev-Shlush D; Abu-Abid S; Mozes M; Chaitchik S; Meller I; Klausner JM
    Cancer; 1997 Mar; 79(6):1129-37. PubMed ID: 9070490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histological response assessment following neoadjuvant isolated limb perfusion in patients with primary, localised, high-grade soft tissue sarcoma.
    Andreou D; Werner M; Pink D; Traub F; Schuler MK; Gosheger G; Jobke B; Reichardt P; Tunn PU
    Int J Hyperthermia; 2016; 32(2):159-64. PubMed ID: 26670477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regional chemotherapy by isolated limb perfusion prior to surgery compared with surgery and post-operative radiotherapy for primary, locally advanced extremity sarcoma: a comparison of matched cohorts.
    Jakob J; Smith HG; Wilkinson MJ; Pencavel T; Miah AB; Thomas JM; Tunn PU; Pilz LR; Strauss DC; Hohenberger P; Hayes AJ
    Clin Sarcoma Res; 2018; 8():12. PubMed ID: 29988594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolated limb perfusion with melphalan and TNF-alpha in the treatment of extremity sarcoma.
    Verhoef C; de Wilt JH; Grünhagen DJ; van Geel AN; ten Hagen TL; Eggermont AM
    Curr Treat Options Oncol; 2007 Dec; 8(6):417-27. PubMed ID: 18066703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of hyperthermic isolated limb perfusion in the treatment of locally recurrent high-grade soft tissue sarcoma of the extremities.
    Farzaliyev F; Touma A; Taeger G; Steinau HU; Hardes J; Streitbürger A; Podleska LE
    World J Surg Oncol; 2020 Dec; 18(1):332. PubMed ID: 33349267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Tumor necrosis factor α and melfalan-based hyperthermic isolated limb perfusion in locally advanced extremity soft tissue sarcomas and melanomas].
    Alegre JF; Duarte M; Sureda González M; Bretcha Boix P; Dussan C; Ballester A; Crespo A; Brugarolas Masllorens A
    Cir Esp; 2012 Feb; 90(2):114-20. PubMed ID: 22225611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolated limb perfusion with TNF-alpha and melphalan in locally advanced soft tissue sarcomas of the extremities.
    Grünhagen DJ; de Wilt JH; van Geel AN; Verhoef C; Eggermont AM
    Recent Results Cancer Res; 2009; 179():257-70. PubMed ID: 19230545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variation in response rates to isolated limb perfusion in different soft-tissue tumour subtypes: an international multi-centre study.
    Reijers SJM; Davies E; Grünhagen DJ; Fiore M; Honore C; Rastrelli M; Vassos N; Podleska LE; Niethard M; Jakob J; Perhavec A; Duarte C; González F; Deroose JP; Stas M; Boecxstaens V; Schrage Y; Snow H; Algarra SM; Said HM; Garcia-Ortega DY; Martin K; Mattsson J; Djafarrian R; Di Lorenzo G; Colombo C; Gronchi A; Matter M; Verhoef C; Olofsson Bagge R; Hohenberger P; Hayes AJ; van Houdt WJ
    Eur J Cancer; 2023 Sep; 190():112949. PubMed ID: 37453241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of age on outcomes after isolated limb perfusion for advanced extremity malignancies.
    Smith HG; Wilkinson MJ; Smith MJF; Strauss DC; Hayes AJ
    Eur J Cancer; 2018 Sep; 100():46-54. PubMed ID: 29940423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Technology insight: Utility of TNF-alpha-based isolated limb perfusion to avoid amputation of irresectable tumors of the extremities.
    Grünhagen DJ; de Wilt JH; ten Hagen TL; Eggermont AM
    Nat Clin Pract Oncol; 2006 Feb; 3(2):94-103. PubMed ID: 16462850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic relevance of ¹⁸F-FDG PET uptake in patients with locally advanced, extremity soft tissue sarcomas undergoing neoadjuvant isolated limb perfusion with TNF-α and melphalan.
    Andreou D; Boldt H; Pink D; Jobke B; Werner M; Schuler M; Reichardt P; Tunn PU
    Eur J Nucl Med Mol Imaging; 2014 Jun; 41(6):1076-83. PubMed ID: 24519553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment modifications in tumour necrosis factor-α (TNF)-based isolated limb perfusion in patients with advanced extremity soft tissue sarcomas.
    Deroose JP; Grünhagen DJ; de Wilt JH; Eggermont AM; Verhoef C
    Eur J Cancer; 2015 Feb; 51(3):367-73. PubMed ID: 25529370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.